Possible explanations for patients with discordant findings of serum thyroglobulin and 131I whole-body scanning

被引:2
|
作者
Ma, C
Kuang, A [1 ]
Xie, JW
Ma, TK
机构
[1] Sichuan Univ, Dept Nucl Med, W China Hosp, Chengdu 610041, Sichuan, Peoples R China
[2] Linyi Peoples Hosp, Dept Stomatol, Linyi, Shandong, Peoples R China
[3] Kunming Univ, Dept Nucl Med, Affiliated Hosp 1, Kunming, Yunnan, Peoples R China
关键词
differentiated thyroid carcinoma; thyroglobulin; I-131; whole-body scanning;
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The long-term monitoring of patients with differentiated thyroid carcinoma (DTC) is essential throughout the patient's life after total or near-total thyroidectomy followed by I-131 remnant ablation and thyroid hormone suppression of thyroid-stimulating hormone (TSH). Sensitive surveillance for DTC recurrence and metastases includes radioiodine diagnostic whole-body scanning (DWBS) and measurement of serum thyroglobulin (Tg) after endogenous or exogenous TSH stimulation. Serum Tg levels during thyroid hormone withdrawal (Tg-off) are usually well correlated with the results of DWBS. In general, undetectable Tg levels with negative DWBS (DWBS-) suggest complete remission, whereas detectable or elevated Tg concentrations are suggestive of the presence of I-131 uptake in local or distant metastases. However, DTC patients with discordant results of Tg measurement and I-131 WBS have been observed in the follow-up study. Negative I-131 DWBS and a positive Tg test (DWBS- Tg(+)) are found in most of these cases. Positive I-131 DWBS and a negative Tg test (DWBS+ Tg(-)), though of uncommon occurrence, has also been demonstrated in a small but significant number of cases. With this scenario, one should first attempt to uncover a cause for possibly false-negative or false-positive I-131 WBS or serum Tg. Explanations for the discordance are speculative but should be scrutinized when confronted with discrepant data in a given patient.
引用
收藏
页码:1473 / 1480
页数:8
相关论文
共 50 条
  • [31] False-positive findings on 131I whole-body scans because of posttraumatic superficial scabs
    Regalbuto, C
    Buscema, M
    Arena, S
    Vigneri, R
    Squatrito, S
    Pezzino, V
    JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (02) : 207 - 209
  • [32] Serum thyroglobulin concentrations and 131I whole-body scan results in patients with differentiated thyroid carcinoma after administration of recombinant human thyroid-stimulating hormone
    David, A
    Blotta, A
    Bondanelli, M
    Rossi, R
    Roti, E
    Braverman, LE
    Busutti, L
    Uberti, ECD
    JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (10) : 1470 - 1475
  • [33] "Picture-in-Picture" Artifact in Post-therapeutic 131I Whole-body Survey: Deceiving Spot View but Unraveling Whole-body Scanning
    Qutbi, Mohsen
    Ahmadi, Reyhane
    MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, 2022, 31 (02) : 142 - 144
  • [34] Prognostic value of thyroglobulin serum levels and 131I whole-body scan after initial treatment of low-risk differentiated thyroid cancer
    Torre, EM
    Carballo, MTL
    Erdozáin, RMR
    Llenas, LF
    Iriarte, MJG
    Layana, JJB
    THYROID, 2004, 14 (04) : 301 - 306
  • [35] The effect of 131I dosages and vitamin C to salivary glands on the post-therapeutic 131I whole-body scans in patients with DTC
    Li, Na
    Jia, Yingnan
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [36] Are there disadvantages in administering 131I ablation therapy in patients with differentiated thyroid carcinoma without a preablative diagnostic 131I whole-body scan?
    Salvatori, M
    Perotti, G
    Rufini, V
    Maussier, ML
    Dottorini, M
    CLINICAL ENDOCRINOLOGY, 2004, 61 (06) : 704 - 710
  • [37] Undetectable ablation thyroglobulin in patients with differentiate thyroid cancer showing 131I uptake on post-ablation therapy whole-body scan
    Alban, F.
    Guelho, D.
    Costa, G.
    Albuquerque, A.
    Pedroso de Lima, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S547 - S547
  • [38] Impact of Radioiodine Therapy in Thyroid Differenciated Carcinoma Patients with Increased Thyroglobulin Level and Negative 131I Whole-Body Scan after Ablation
    Bota, E. C.
    Lopes, F. G.
    Santos, J. A. M.
    Soares, O.
    Bastos, A. L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S111 - S111
  • [39] Response to the letter to the editor "18F-FDG-PET/CT indication in patients affected by differentiated thyroid cancer with elevated serum thyroglobulin and negative whole-body scanning after therapy with 131I"
    Albano, Domenico
    Tulchinsky, Mark
    Bertagna, Francesco
    Giubbini, Raffaele
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (13) : 2952 - 2953
  • [40] Comparison of 121I and 131I for whole-body imaging in thyroid cancer
    Sarkar, SD
    Kalapparambath, TP
    Palestro, CJ
    JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (05) : 632 - 634